Cite

HARVARD Citation

    Innocenti, I. et al. (2019). HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis. Leukemia & lymphoma. 60 (5), pp. 1340-1342. [Online]. 
  
Back to record